| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.05 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
| mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.05 |
| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.05 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
| mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
| mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
| mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.06 |